Research map: Long-term adherence to glucose-lowering therapy and cardiovascular risk in type 2 diabetes: a nationwide cohort study

Back to the article

Papers in this map

  1. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation · Mary E. Charlson · 1987 · 50679 citations · Cited by this paper
  2. Estimating the Potential Burden of Clinically Significant Hantavirus Cases in Argentina · 2026 · Related
  3. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes · Bernard Zinman · 2015 · 12293 citations · Cited by this paper
  4. GLP-1 receptor agonists in type 1 diabetes: expanding the therapeutic landscape beyond insulin · 2026 · Related
  5. Adherence to Medication · Lars Osterberg · 2005 · 8010 citations · Cited by this paper
  6. Closing the Implementation Gap: New Models of Care to End Chronic Liver Disease · 2026 · Related
  7. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes · Rury R. Holman · 2008 · 7826 citations · Cited by this paper
  8. Ending the Chronic Liver Disease Public Health Threat: Systemic Challenges Through the Patient Lens · 2026 · Related
  9. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies · The Emerging Risk Factors Collaboration · 2010 · 5229 citations · Cited by this paper
  10. Preparing Europe for Recurrent Autochthonous Dengue Transmission: Public Health Implications and Preparedness Priorities · 2026 · Related
  11. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes · William C. Duckworth · 2008 · 4806 citations · Cited by this paper
  12. From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid Therapy · 2026 · Related
  13. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 · Kanyin Liane Ong · 2023 · 4687 citations · Cited by this paper
  14. Nordic AI-Health: a unique opportunity for discovery and clinical impact · 2026 · Related
  15. Atherosclerosis · Peter Libby · 2019 · 3159 citations · Cited by this paper
  16. Safety of the Dengue Vaccine TAK-003 and Factors Associated with Adverse Events in Travellers from Non-Endemic Areas: A Real-World Prospective Multicentre Pharmacovigilance Cohort Study in Spain · 2026 · Related
  17. Liraglutide and Renal Outcomes in Type 2 Diabetes · Johannes F.E. Mann · 2017 · 1269 citations · Cited by this paper
  18. Assessing Europe's policy readiness to confront the MASLD/MASH public health threat · 2026 · Related
  19. The Bayesian information criterion: background, derivation, and applications · Andrew A. Neath · 2011 · 1102 citations · Cited by this paper
  20. Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension · 2026 · Related
  21. Group-based multi-trajectory modeling · Daniel S. Nagin · 2016 · 977 citations · Cited by this paper
  22. Glycemic Control and Excess Mortality in Type 1 Diabetes · Marcus Lind · 2014 · 970 citations · Cited by this paper
  23. Economic impact of medication non-adherence by disease groups: a systematic review · Rachelle Louise Cutler · 2018 · 930 citations · Cited by this paper
  24. Determinants of patient adherence: a review of systematic reviews · Przemysław Kardas · 2013 · 817 citations · Cited by this paper
  25. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 · Nuha A. ElSayed · 2024 · 709 citations · Cited by this paper
  26. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data · Sudeep Karve · 2009 · 619 citations · Cited by this paper
  27. Pathophysiology of heart failure · Robert H. G. Schwinger · 2021 · 428 citations · Cited by this paper
  28. Group-based Trajectory Models · Jessica Myers Franklin · 2013 · 262 citations · Cited by this paper
  29. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis · Kamlesh K. Khunti · 2017 · 228 citations · Cited by this paper
  30. Research and scholarly methods: Measuring medication adherence · Kanya K. Shah · 2023 · 69 citations · Cited by this paper
  31. Early-onset type 2 diabetes: the next major diabetes transition · Andrea O. Y. Luk · 2025 · 69 citations · Cited by this paper
  32. Adherence to type 2 diabetes management · Nitisha Khunti · 2019 · 63 citations · Cited by this paper
  33. Validation of Register-Based Diabetes Classifiers in Danish Data · Anders Aasted Isaksen · 2023 · 55 citations · Cited by this paper
  34. Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review · Sara Denicolò · 2021 · 44 citations · Cited by this paper
  35. Optimal cut-off points for adherence measure among patients with type 2 diabetes in primary care clinics: a retrospective analysis · Ming Tsuey Lim · 2021 · 28 citations · Cited by this paper
  36. SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes · Simon Kok Jensen · 2026 · 11 citations · Cited by this paper
  37. Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes · Romain S. Neugebauer · 2025 · 10 citations · Cited by this paper
  38. Group-based trajectory analysis identifies varying diabetes-related cost trajectories among type 2 diabetes patients in Texas: an empirical study using commercial insurance · Gang Han · 2023 · 4 citations · Cited by this paper
  39. Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study · Crystal Lee · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)